Skip to content

Repetitive Transcranial Magnetic Stimulation (rTMS) in The Treatment of Gambling Disorder in Indonesia

Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in The Treatment of Gambling Disorder in Indonesia: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06182137
Enrollment
30
Registered
2023-12-26
Start date
2024-12-31
Completion date
2025-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gambling Disorder

Brief summary

Research has shown that cognitive-behavioral therapy (CBT) is an effective treatment for gambling disorder. Several studies had also been done to evaluate the effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) in addiction management, particularly in alleviating craving. A randomised controlled trial (RCT) of 30 subjects would be conducted to evaluate the effectiveness of transmodalistic therapy with a combination of rTMS and CBT for online gambling disorder.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation (rTMS)

A randomised controlled trial (RCT) of 60 subjects will be conducted to evaluate the effectiveness of transmodalistic therapy with a combination of rTMS and Cognitive Behavioral Therapy (CBT) for online gambling disorder.

Sponsors

Radboud University Medical Center
CollaboratorOTHER
Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Subjects with pathological gambling (SOGS score ≥ 5) * Subjects aged 18-59 years old * Subjects who understand Bahasa Indonesia * Subjects who agree to participate and receive treatment

Exclusion criteria

* Subjects with history of psychotic disorder, personality disorder, or sleep disorder according to ICD-11 * Subjects with history of neurostimulation * Subjects with history of medical implant * Subjects with history of severe neurological disorder, which causes seizure or loss of consciousness * Subjects with intellectual disability * Subjects with endocrinological disorders * Subjects with contraindication during prior MR or other related procedures * Subjects who are currently or expecting pregnancy * Subjects with history of substance use in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Improvement in pathological gambling scoreBaseline (week 0), interim assessment (week 3), post-intervention (week 6), follow up at 3 months and 6 months after interventionSouth Oaks Gambling Screen (SOGS), Indonesian version, with minimum score of 0 and maximum score of 20. A score of 0-2 indicates no pathological gambling; a score of 3-4 indicates problems with gambling, and a score of 5 or more indicates that the subject is a probable pathological gambler. Lower score indicates a better outcome.
Improvement in gambling symptoms severityBaseline (week 0), interim assessment (week 3), post-intervention (week 6), follow up at 3 months and 6 months after interventionGambling Symptoms Assessment Scale (G-SAS), Indonesian version, with minimum score of 0 and maximum score of 48. Interpretations: Mild (8-20), Moderate (21-30), Severe (31-40), and Extreme (41-48). Lower score indicates a better outcome.
Improvement in gambling urgeBaseline (week 0), interim assessment (week 3), post-intervention (week 6), follow up at 3 months and 6 months after interventionGambling Urge Scale (GUS), Indonesian version, with minimum score of 0 and maximum score of 42. Lower score indicates a better outcome.
Improvement in gambling related cognitive distortionsBaseline (week 0), interim assessment (week 3), post-intervention (week 6), follow up at 3 months and 6 months after interventionGambling Related Cognitions Scale (GRCS), Indonesian version, with 5 cognitive distortion domains. Lower score indicates a better outcome.

Secondary

MeasureTime frameDescription
Improvement in gambling-related cognitive functionsBaseline (week 0), interim assessment (week 3), post-intervention (week 6), follow up at 3 months and 6 months after interventionCreyos (formerly Cambridge Brain Sciences, CBS), measures 12 domains of cognitive function with the subject results compared with their respective average age results in percentile. A higher percentile is a better outcome.
Improvement in depression symptomsBaseline (week 0), post-intervention (week 6), follow up at 3 months and 6 months after interventionBeck Depression Inventory-II (BDI II), measures severity of depression symptoms, with minimum score of 0 and maximum score of 63. Interpretation: (1) minimal (0-13), (2) mild (14-19), (3) moderate (20-28), and (4) severe (29-63). Lower score indicates a better outcome.
Improvement in self-reported psychological distressBaseline (week 0), post-intervention (week 6), follow up at 3 months and 6 months after intervention20-item Self-Reporting Questionnaire (SRQ-20), Indonesian version, measures non-specific psychological distress. Score range 0-20, with scores \>10 classified as mental distress. Lower score indicates a better outcome.
Improvement of overall severity of illnessBaseline (week 0), interim assessment (week 3), post-intervention (week 6), follow up at 3 months and 6 months after interventionClinical Global Impression (CGI), measure overall severity of illness and improvement observed by the clinician. Lower score indicates a better outcome.

Countries

Indonesia

Contacts

Primary ContactKevin Surya Kusuma, MD
kevinsurya97@gmail.com+6282110603921

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026